Search
for
Sort by
Research 271–300 of 1000+
- Frontal fibrosing alopecia: A review of disease pathogenesis
- Skin, hair and beyond: the impact of menopause
- A new target for squamous cell skin cancer?
- The prevention of benign prostatic hyperplasia (bph)
- Treatment of hyperandrogenism in women
- The effects of synthetic 19-norprogestins on osteoblastic cell function are mediated by their non-phenolic reduced metabolites
- TRPV Channels in Osteoarthritis: A Comprehensive Review
- Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings
- Allopregnanolone-mediated protective effects of progesterone on tributyltin-induced neuronal injury in rat hippocampal slices
- The Brown Algae Ishige sinicola Extract Ameliorates Ovariectomy-Induced Bone Loss in Rats and Suppresses Osteoclastogenesis through Downregulation of NFATc1/c-Fos
- Evaluation of Biological Activity Exerted by an Aza-bicyclocarboxylic acid Derivative using Anischemia-Reperfusion Injury Model
- Canagliflozin alleviates progestin resistance by suppressing RARβ/CRABP2 signaling in THRB knockout endometrial cancer cells
- The X Factor in Immunity: Sex Differences Shaped by the X Chromosome
- Using the Mechanisms of Action Involved in the Pathogenesis of Androgenetic Alopecia to Treat Hair Loss
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Growth Hormone and the Human Hair Follicle
- No. 350-Hirsutism: Evaluation and Treatment
- The human skin as a hormone target and an endocrine gland
- Chemical Profiling, Pharmacological Insights and In Silico Studies of Methanol Seed Extract of Sterculia foetida
- The Off-Label Use of Selective Serotonin Reuptake Inhibitors for Sexual Behavior Management: Risks and Considerations
- Emerging Roles for Ion Channels in Ovarian Cancer: Pathomechanisms and Pharmacological Treatment
- Management of hair loss associated with endocrine therapy in patients with breast cancer: an overview
- Androgenic disorders
- COMBINATION OF AN ANTIANDROGEN AND A 5α-REDUCTASE INHIBITOR: A FURTHER STEP TOWARDS TOTAL ANDROGEN BLOCKADE?
- Androgen treatment in women
- Hormonal therapy for acne: why not as first line therapy? facts and controversies
- A Case of Familial Male-limited Precocious Puberty with a Novel Mutation
- Monocyclic Aromatic Compounds
- USE OF SPIRONOLACTONE IN COMBINATION WITH AN ORAL CONTRACEPTIVE IN TREATMENT OF HIRSUTISM
- 2-Substituted 4-(Thio)chromenone 6-<i>O</i>-Sulfamates: Potent Inhibitors of Human Steroid Sulfatase